Treating the inflammation in lymphedema
- D-CHAB
- IPW
Prof. Detmar and collaborators could show that the immune system suppresses the development of lymphedema using regulatory T cells. Anti-inflammatory therapies could therefore be the key to treating this previously incurable condition.
Reference
Gousopoulos E, Proulx ST, Bachmann SB, Scholl J, Dionyssiou D, Demiri E, Halin C, Dieterich LC, Detmar M: Regulatory T cell transfer ameliorates lymphedema and promotes lymphatic vessel function, JCI Insight 2016, 1: e89081, doi: external page10.1172/jci.insight.89081call_made